You have 9 free searches left this month | for more free features.

RAEB

Showing 1 - 25 of 54

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myelodysplastic Syndrome RAEB-I or RAEB-II, Refractory Acute Myeloid Leukemia, Refractory CML Myeloid Blast Crisis Trial in

Completed
  • Myelodysplastic Syndrome RAEB-I or RAEB-II
  • +2 more
  • GM-CSF secreting leukemia vaccine
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 28, 2022

Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

Recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • +4 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jan 15, 2021

Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Tampa, Cleveland (Idarubicin, Cytarabine, Lenalidomide (Revlimid®))

Completed
  • Myelodysplastic Syndrome
  • Acute Myeloid Leukemia
  • Tampa, Florida
  • +1 more
Dec 1, 2020

Myelodysplastic Syndrome (MDS) Trial run by the NHLBI (ON 01910 Na)

Completed
  • Myelodysplastic Syndrome (MDS)
  • ON 01910 Na
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

A Prospective, Multicentre European Registry for Newly Diagnosed

Recruiting
  • Myelodysplastic Syndromes (MDS)
  • No interventions
  • Innsbruck, Austria
  • +17 more
Dec 28, 2020

Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or

Terminated
  • Myelodysplastic Syndrome
  • +3 more
  • La Jolla, California
  • +157 more
Sep 22, 2022

MDS Over Time - Comparison of Treated vs Untreated Patients

Completed
  • Myelodysplastic Syndromes
    • Vienna, Austria
      Hanusch Krankenhaus, 3.Medizinische Abteilung
    Nov 21, 2022

    Acute Myeloid Leukemia Trial in Worldwide (hematopoietic cell transplantation, Non-Transplant treatment approach for

    Terminated
    • Acute Myeloid Leukemia
    • hematopoietic cell transplantation
    • Non-Transplant treatment approach for consolidation
    • Melbourne Victoria, Australia
    • +47 more
    Oct 6, 2021

    Changing Over Time of Ascorbic Acid After Chemotherapy

    Active, not recruiting
    • Leukemia (Both ALL and AML)
    • +2 more
    • blood withdrawn
    • Maastricht, Limburg, Netherlands
      MUMC+
    Sep 23, 2021

    MDS-EB Trial in Jinan (Allogeneic NK cell regimen group)

    Not yet recruiting
    • MDS-EB
    • Allogeneic NK cell regimen group
    • Jinan, Shandong, China
      The 2nd Hospital of Shandong University
    Oct 21, 2020

    MDS Trial in Worldwide (Oral Azacitidine, Durvalumab)

    Active, not recruiting
    • Myelodysplastic Syndromes
    • New Haven, Connecticut
    • +65 more
    Aug 19, 2022

    MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)

    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • ON 01910.Na
    • Scottsdale, Arizona
    • +86 more
    Jun 29, 2020

    Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral

    Completed
    • Myelodysplastic Syndrome
    • +2 more
    • Gilbert, Arizona
    • +12 more
    Jun 15, 2021

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Australia, Canada, United States

    Completed
    • Acute Myelogenous Leukemia
    • +4 more
    • Single Umbilical Cord Blood Unit Transplant
    • +6 more
    • Birmingham, Alabama
    • +37 more
    Oct 13, 2021

    MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)

    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • rigosertib sodium
    • Stanford, California
    • +34 more
    Jun 29, 2020

    Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Duesseldorf (Lenalidomide, Azacitidine, Donor

    Completed
    • Leukemia, Myeloid, Acute
    • +2 more
    • Duesseldorf, NRW, Germany
      University Hospital Duesseldorf, Dept. of Hematology, Oncology a
    May 26, 2020

    Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts Trial in

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • GM-K562/leukemia cell vaccine
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Sep 15, 2020

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Multiple Myeloma Trial in Boston (CM-CS1 T-cell infusion)

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • CM-CS1 T-cell infusion
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    May 30, 2018

    Hodgkin Lymphoma, Lymphocytic Leukemia, Mixed Cell Leukemia Trial run by the NCI (Stem cell transplantation)

    Completed
    • Hodgkin Lymphoma
    • +8 more
    • Stem cell transplantation
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 13, 2019

    Serum Erythropoietin Level,Ferritin Level and Fibrinogen in

    Unknown status
    • MDS
    • (no location specified)
    Sep 28, 2020

    Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing

    Unknown status
    • Myelodysplastic Syndrome
    • Chemotherapy
    • Demethylation drug
    • Chemotherapy regimen
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Dec 6, 2017

    Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in

    Completed
    • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
    • +13 more
    • Salt Lake City, Utah
    • +2 more
    Jan 15, 2020

    Myelodysplastic Syndrome Trial in United States (CC-11006)

    Terminated
    • Myelodysplastic Syndrome
    • Tampa, Florida
    • +6 more
    Dec 11, 2019

    Acute Myeloid Leukemia Trial in Singapore, United States (Cytarabine, Daunorubicin, Etoposide)

    Completed
    • Acute Myeloid Leukemia
    • Palo Alto, California
    • +7 more
    Aug 6, 2021

    MDS Trial in Taiwan (Azacitidine)

    Completed
    • Myelodysplastic Syndromes
    • Changhua, Taiwan
    • +10 more
    Nov 21, 2019